home / stock / tak / tak news


TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 05/16/23

Stock Information

Company Name: Takeda Pharmaceutical Company Limited American Depositary Shares
Stock Symbol: TAK
Market: NYSE
Website: takeda.com

Menu

TAK TAK Quote TAK Short TAK News TAK Articles TAK Message Board
Get TAK Alerts

News, Short Squeeze, Breakout and More Instantly...

TAK - What To Expect From GSK In 2023

2023-05-16 01:29:25 ET Summary GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. Vaccine sales were $2,493 million in Q1 2023, up 11.9% year-over-year, mainly due to Fluarix and FluLaval, which regulators approved t...

TAK - Takeda Pharmaceutical Company Limited (TAK) Q4 2022 Earnings Call Transcript

2023-05-11 22:42:09 ET Takeda Pharmaceutical Company Limited (TAK) Q4 2022 Results Conference Call May 11, 2023 06:00 AM ET Company Participants Christopher O’Reilly - Global Head of IR & Global Finance Christophe Weber - President, CEO & Representativ...

TAK - Phathom gains as Evercore ISI upgrades on potential vonoprazan approval

2023-05-11 09:37:36 ET Phathom Pharmaceuticals ( NASDAQ: PHAT ) added ~8% on Thursday morning after Evercore ISI upgraded the biopharma, citing a potential FDA approval for its initial product candidate, vonoprazan, targeted at gastrointestinal disorders. “Phathoms&#x...

TAK - Takeda FY22 sales grow but FY23 outlook weighed down by generic impact

2023-05-11 07:05:23 ET Takeda Pharmaceutical ( NYSE: TAK ) FY22 revenue grew but noted that its FY2023 outlook reflects challenges from generics impact and lower COVID-19 vaccine contributions. The Japanese drugmaker's Core EPS grew +31.5% at actual % change (+13.9% at CER b...

TAK - Takeda Pharmaceutical Non-GAAP EPS of ¥558.00, revenue of ¥4.03B; initiates FY23 guidance

2023-05-11 03:31:04 ET Takeda Pharmaceutical press release ( NYSE: TAK ): FY Non-GAAP EPS of ¥558.00. Revenue of ¥4.03B growth of +12.8%; Core Revenue Growth of +3.5% at Constant Exchange Rate Driven by Growth & Launch Products; Reported EPS Gro...

TAK - Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook

Full Year Reported Revenue Growth of + 12.8%; Core Revenue Growth of +3.5% at Constant Exchange Rate Driven by Growth & Launch Products; Reported EPS Growth of +38.8% Achieved Core Operating Profit of 1,188.4 Billion Yen – Exceeding 1 Trillion Yen for the First Tim ...

TAK - Takeda Presents Real-World Clinical Effectiveness and Safety Results of Vedolizumab (ENTYVIO®) and Ustekinumab as First-Line Biologic Treatment for Crohn's Disease

Takeda Presents Real-World Clinical Effectiveness and Safety Results of Vedolizumab (ENTYVIO®) and Ustekinumab as First-Line Biologic Treatment for Crohn's Disease Canada NewsWire TORONTO , May 10, 2023 /CNW/ - Takeda Canada Inc. ("Takeda") announces results...

TAK - Earnings Week Ahead: Fox Corporation, Disney, Airbnb, and more

2023-05-05 14:00:36 ET Earnings season continues next week, although the pace of releases begins to slow. Entertainment companies provide key highlights during the period, with reports due out from Disney ( DIS ) and Fox ( FOX ). Outside of media, both the pharmaceutical and EV ...

TAK - Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years

2023-05-03 06:08:01 ET The rate of drug overdose deaths involving fentanyl rose 279% between 2016 and 2021, according to a report from the U.S. Centers for Disease Control and Prevention (CDC). Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times...

TAK - Healthcare And Facebook Help Propel My 25 Stock ~$424K Portfolio To New Highs In April

2023-05-01 23:53:08 ET Summary My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Great performances by Arrowhead Pharmaceuticals and Meta propelled my portfolio again to all-time highs and mar...

Previous 10 Next 10